Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Microneedle Drug Delivery Systems Market, by Type
1.4.2 Asia Pacific Microneedle Drug Delivery Systems Market, by Application
1.4.3 Asia Pacific Microneedle Drug Delivery Systems Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Recent Industry Wide Strategic Developments - Global
3.1 Partnerships, Collaborations and Agreements
3.2 Product Launches and Product Expansions
3.3 Acquisition and Mergers
3.4 Geographical Expansions
3.5 Top Winning Strategies
3.5.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.5.2 Key Strategic Move: (Product Launches and Product Expansions: 2017, Jun – 2021, Jun) Leading Players
Chapter 4. Asia Pacific Microneedle Drug Delivery Systems Market by Type
4.1 Asia Pacific Hollow Market by Country
4.2 Asia Pacific Dissolving Market by Country
4.3 Asia Pacific Solid Market by Country
4.4 Asia Pacific Coated Market by Country
4.5 Asia Pacific Other Types Market by Country
Chapter 5. Asia Pacific Microneedle Drug Delivery Systems Market by Application
5.1 Asia Pacific Drug delivery Market by Country
5.2 Asia Pacific Cancer Therapy Market by Country
5.3 Asia Pacific Vaccine delivery Market by Country
5.4 Asia Pacific Pain Management Market by Country
5.5 Asia Pacific Dermatology Market by Country
5.6 Asia Pacific Other Applications Market by Country
Chapter 6. Asia Pacific Microneedle Drug Delivery Systems Market by Material
6.1 Asia Pacific Metal Market by Country
6.2 Asia Pacific Polymer Market by Country
6.3 Asia Pacific Silicon Market by Country
6.4 Asia Pacific Other Material Market by Country
Chapter 7. Asia Pacific Microneedle Drug Delivery Systems Market by Country
7.1 China Microneedle Drug Delivery Systems Market
7.1.1 China Microneedle Drug Delivery Systems Market by Type
7.1.2 China Microneedle Drug Delivery Systems Market by Application
7.1.3 China Microneedle Drug Delivery Systems Market by Material
7.2 Japan Microneedle Drug Delivery Systems Market
7.2.1 Japan Microneedle Drug Delivery Systems Market by Type
7.2.2 Japan Microneedle Drug Delivery Systems Market by Application
7.2.3 Japan Microneedle Drug Delivery Systems Market by Material
7.3 India Microneedle Drug Delivery Systems Market
7.3.1 India Microneedle Drug Delivery Systems Market by Type
7.3.2 India Microneedle Drug Delivery Systems Market by Application
7.3.3 India Microneedle Drug Delivery Systems Market by Material
7.4 South Korea Microneedle Drug Delivery Systems Market
7.4.1 South Korea Microneedle Drug Delivery Systems Market by Type
7.4.2 South Korea Microneedle Drug Delivery Systems Market by Application
7.4.3 South Korea Microneedle Drug Delivery Systems Market by Material
7.5 Singapore Microneedle Drug Delivery Systems Market
7.5.1 Singapore Microneedle Drug Delivery Systems Market by Type
7.5.2 Singapore Microneedle Drug Delivery Systems Market by Application
7.5.3 Singapore Microneedle Drug Delivery Systems Market by Material
7.6 Malaysia Microneedle Drug Delivery Systems Market
7.6.1 Malaysia Microneedle Drug Delivery Systems Market by Type
7.6.2 Malaysia Microneedle Drug Delivery Systems Market by Application
7.6.3 Malaysia Microneedle Drug Delivery Systems Market by Material
7.7 Rest of Asia Pacific Microneedle Drug Delivery Systems Market
7.7.1 Rest of Asia Pacific Microneedle Drug Delivery Systems Market by Type
7.7.2 Rest of Asia Pacific Microneedle Drug Delivery Systems Market by Application
7.7.3 Rest of Asia Pacific Microneedle Drug Delivery Systems Market by Material
Chapter 8. Company Profiles
8.1 Nitto Denko Corporation
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Product Launches and Product Expansions:
8.2 Becton, Dickinson and Company
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.5.2 Acquisition and Mergers:
8.2.5.3 Geographical Expansions:
8.3 AdminMed nanoBioSciences LLC
8.3.1 Company Overview
8.4 Zosano Pharma Corporation
8.4.1 Company Overview
8.4.2 Recent strategies and developments:
8.4.2.1 Partnerships, Collaborations, and Agreements:
8.5 Raphas Co., Ltd.
8.5.1 Company Overview
8.6 Nanopass Technologies Ltd.
8.6.1 Company Overview
8.6.2 Recent strategies and developments:
8.6.2.1 Partnerships, Collaborations, and Agreements:
8.7 Corium Inc. (Gurnet Point Capital)
8.7.1 Company Overview
8.7.2 Recent strategies and developments:
8.7.2.1 Partnerships, Collaborations, and Agreements:
8.8 Zealand Pharma A/S (Valeritas, Inc.)
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Research & Development Expenses
8.8.4 Recent strategies and developments:
8.8.4.1 Geographical Expansions:
8.9 Endoderma Co., Ltd.
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Geographical Expansions:
8.10. Innoture Medical Technology Limited
8.10.1 Company Overview
Unique Offerings 